MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 142 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.85 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $974,000 | -34.6% | 238,650 | +1.8% | 0.01% | -40.0% |
Q3 2016 | $1,489,000 | +18.8% | 234,480 | +0.9% | 0.02% | +7.1% |
Q2 2016 | $1,253,000 | -35.6% | 232,430 | 0.0% | 0.01% | -46.2% |
Q1 2016 | $1,945,000 | -66.5% | 232,430 | -68.4% | 0.03% | -61.8% |
Q4 2015 | $5,812,000 | -11.3% | 735,710 | -4.5% | 0.07% | -10.5% |
Q3 2015 | $6,553,000 | -31.2% | 770,080 | 0.0% | 0.08% | -25.5% |
Q2 2015 | $9,522,000 | +234.0% | 770,080 | +220.9% | 0.10% | +240.0% |
Q1 2015 | $2,851,000 | – | 239,980 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lagoda Investment Management, L.P. | 1,560,530 | $17,634,000 | 4.71% |
B & T Capital Management DBA Alpha Capital Management | 280,113 | $3,165,000 | 2.22% |
Schonfeld Group Holdings LLC | 10,000 | $113,000 | 1.51% |
COLUMBIA CAPITAL LLC | 117,702 | $1,331,000 | 1.45% |
Portolan Capital Management | 607,288 | $6,862,000 | 1.38% |
Price Capital Management, Inc. | 118,047 | $1,334,000 | 1.18% |
GARRISON BRADFORD & ASSOCIATES INC | 90,700 | $1,025,000 | 0.93% |
Opus Point Partners Management, LLC | 72,009 | $814,000 | 0.80% |
EAM Investors, LLC | 412,233 | $4,658,000 | 0.65% |
TFS CAPITAL LLC | 476,105 | $5,380,000 | 0.51% |